TSE:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis C$5.88 -0.05 (-0.84%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Aurora Cannabis Stock (TSE:ACB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aurora Cannabis alerts:Sign Up Key Stats Today's RangeC$5.79▼C$6.0750-Day RangeC$5.50▼C$9.5052-Week RangeC$4.95▼C$12.85Volume555,696 shsAverage Volume559,247 shsMarket CapitalizationC$321.68 millionP/E RatioN/ADividend YieldN/APrice TargetC$8.75Consensus RatingBuy Company OverviewAurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.Read More… Remove Ads Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingAurora Cannabis has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAurora Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -7.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -7.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACB. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACB. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 9 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$124,524.00 in company stock.Percentage Held by InstitutionsOnly 13.38% of the stock of Aurora Cannabis is held by institutions.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address ACB Stock News HeadlinesWhat to Know About Canadian Cannabis Stocks for 2025February 27, 2025 | msn.comIs Aurora Cannabis stock a good buy right now?February 27, 2025 | ca.finance.yahoo.comCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…April 15, 2025 | Crypto Swap Profits (Ad)Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?February 27, 2025 | fool.caAurora Cannabis stock jumps over 50% after 'record-breaking' quarterFebruary 6, 2025 | ca.finance.yahoo.comAurora Cannabis turns bullish after earnings [Video]February 6, 2025 | fxstreet.comAurora Cannabis reports Q3 revenue C$88.2M vs. C$64.4M last yearFebruary 5, 2025 | markets.businessinsider.comAurora Cannabis announces corporate updateJanuary 24, 2025 | msn.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at C$6.11 at the beginning of the year. Since then, ACB shares have decreased by 3.8% and is now trading at C$5.88. View the best growth stocks for 2025 here. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (TSE:ACB) announced its quarterly earnings results on Wednesday, November, 6th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of ($0.30) by $0.35. Aurora Cannabis had a negative trailing twelve-month return on equity of 8.36% and a negative net margin of 22.55%. How do I buy shares of Aurora Cannabis? Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF). Company Calendar Last Earnings11/06/2024Today4/14/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ACB CIKN/A Webauroramj.com Phone+1-604-3625207FaxN/AEmployees1,073Year FoundedN/APrice Target and Rating Average Stock Price TargetC$8.75 High Stock Price TargetC$9.00 Low Stock Price TargetC$8.50 Potential Upside/Downside+48.8%Consensus RatingBuy Rating Score (0-4)3.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-44,163,091.00 Net Margins-22.55% Pretax MarginN/A Return on Equity-8.36% Return on Assets-1.87% Debt Debt-to-Equity Ratio18.72 Current Ratio3.42 Quick Ratio2.48 Sales & Book Value Annual SalesC$195.83 million Price / Sales1.64 Cash FlowC$4.72 per share Price / Cash Flow1.25 Book ValueC$11.03 per share Price / Book0.53Miscellaneous Outstanding Shares54,708,189Free FloatN/AMarket CapC$321.68 million OptionableNot Optionable Beta2.71 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (TSE:ACB) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.